Scientists have found that they are able to “switch off,” or silence, a gene that is responsible for an aggressive form of breast cancer.
Researchers worked with two known breast cancer genes, Rab27a and TRAF31P2, to test the effects of “switching them off.” When the researchers “switched off” the TRAF31P2 gene, they found that this suppressed the growth of the patients’ tumors and prevented metastasis for up to one year. Furthermore, previously existing tumors shrank until undetectable.
The final takeaway from the study concluded that the TRAF3IP2 gene could be targeted in a novel therapeutic approach.
To read more about this study, please click here.
Source: https://www.nature.com/articles/s41598-020-64781-z.epdf?sharing_token=g5pMd4_e6Nk6moKYt8K719RgN0jAjWel9jnR3ZoTv0NqsC8K8p3YcQkhq3pkVMte2MxGIYJilndbyCeof7SHjPMZP5hYcb2EeflxdT2dIdfwhRxJzVCGaDZq4LiDTtpIlqpA9_XIwKptc-BPRuaFkiV58_Sfnm0joShFtH4mRsQ%3D
*Online Bonus Content: This has not been peer reviewed. The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal.
